Common genetic variants found in HLA and KIR immune genes in autism spectrum disorder

Frontiers in Neuroscience

Volumn 10, Issue OCT, 2016, Pages

  Torres, Anthony R ^a   Sweeten, Thayne L ^a   Johnson, Randall C ^b   Odell, Dennis ^a   Westover, Jonna B ^a   Bray Ward, Patricia ^a   Ward, David C ^a   Davies, Christopher J ^a   Thomas, Aaron J ^c   Croen, Lisa A ^a   Benson, Michael ^a  

^a UTAH STATE UNIVERSITY   (United States)

^b SAIC FREDERICK INC   (United States)

^c DIVISION OF RESEARCH   (United States)

Author keywords

Autism; Common genetic variant; Haplotype; HLA; KIR

Indexed keywords

AUTOANTIBODY; HLA A2 ANTIGEN; HLA DR4 ANTIGEN; HLA G ANTIGEN;

2DS1 GENE; 2DS2 GENE; 3DS1 GENE; ADAPTIVE IMMUNITY; ALLELE; AUTISM; B LYMPHOCYTE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HLA GENE; HUMAN; IMMUNOGENETICS; IMMUNOLOGY; INNATE IMMUNITY; KIR GENE; REVIEW; T LYMPHOCYTE;

EID: 84997328024     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2016.00463     Document Type: Review

References (83)

1. Abdallah, M. W., Larsen, N., Grove, J., Bonefeld-Jørgensen, E. C., Nørgaard-Pedersen, B., Hougaard, D. M., et al. (2013). Neonatal chemokine levels and risk of autism spectrum disorders: findings from a Danish historic birth cohort follow-up study. Cytokine 61, 370-376. doi: 10.1016/j.cyto.2012.11.015.
2. Al-Ayadhi, L. Y., and Mostafa, G. A. (2012). Elevated serum levels of interleukin-17A in children with autism. J. Neuroinflammation 9:158. doi: 10.1186/1742-2094-9-158.
3. Al-Hakbany, M., Awadallah, S., and Al-Ayadhi, L. (2014). The relationship of HLA Class I and II alleles and haplotypes with autism: a case control study. Autism Res. Treat. 2014:242048. doi: 10.1155/2014/242048.
4. Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I. N., and Van de Water, J. (2011). Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J. Neuroimmunol. 232, 196-199. doi: 10.1016/j.jneuroim.2010.10.025.
5. Bailey, A., Le Couteur, A., Gottesman, I., Bolton, P., Simonoff, E., Yuzda, E., et al. (1995). Autism as a strongly genetic disorder: evidence from a british twin study. Psychol. Med. 25, 63-77. doi: 10.1017/S0033291700028099.
6. Bedoya, S. K., Lam, B., Lau, K., and Larkin, J. III. (2013). Th17 cells in immunity and autoimmunity. Clin. Dev. Immunol. 2013:986789. doi: 10.1155/2013/986789.
7. Bolton, P., Macdonald, H., Pickles, A., Rios, P., Goode, S., Crowson, M., et al. (1994). A case-control family history study of autism. J. Child Psychol. Psychiatry 35, 877-900. doi: 10.1111/j.1469-7610.1994.tb02300.x.
8. Braunschweig, D., and Van de Water, J. (2012). Maternal autoantibodies in autism. Arch. Neurol. 69, 693-699. doi: 10.1001/archneurol.2011.2506.
9. Bunce, M., and Passey, B. (2013). HLA typing by sequence-specific primers. Methods Mol. Biol. 1034, 147-159. doi: 10.1007/978-1-62703-493-7_8.
10. Cacci, E., Claasen, J.-H., and Kokaia, Z. (2005). Microglia-derived tumor necrosis factor-alpha exaggerates death of newborn hippocampal progenitor cells in vitro. J. Neurosci. Res. 80, 789-797. doi: 10.1002/jnr.20531.
11. Carapito, R., Radosavljevic, M., and Bahram, S. (in press). Next-generation sequencing of the HLA locus: methods and impacts on HLA typing, population genetics and disease association studies. Hum. Immunol. doi: 10.1016/j.humimm.2016.04.002.
12. Chien, Y. L., Wu, Y. Y., Chen, C. H., Gau, S. S., Huang, Y. S., Chien, W. H., et al. (2011). Association of HLA-DRB1 alleles and neuropsychological function in autism. Psychiatr. Genet. 22, 46-49. doi: 10.1097/YPG.0b013e32834915ae.
13. Choi, G. B., Yim, Y. S., Wong, H., Kim, S., Kim, H., Kim, S. V., et al. (2016). The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science 351, 933-939. doi: 10.1126/science.aad0314.
14. Constantino, J. N., Todorov, A., and Hilton, C. (2013). Autism recurrence in half siblings: strong support for genetic mechanisms of transmission in ASD. Mol. Psychiatry 18, 137-138. doi: 10.1038/mp.2012.9.
15. Croen, L. A., Braunschweig, D., Haapanen, L., Yoshida, C. K., Fireman, B., Grether, J. K., et al. (2008). Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study. Biol. Psychiatry 64, 583-588. doi: 10.1016/j.biopsych.2008.05.006.
16. de Almeida, D. E., Ling, S., and Holoshitz, J. (2011). New insights into the functional role of the rheumatoid arthritis shared epitope. FEBS Lett. 585, 3619-3626. doi: 10.1016/j.febslet.2011.03.035.
17. De Almeida, D. E., Ling, S., Pi, X., Hartmann-Scruggs, A. M., Pumpens, P., and Holoshitz, J. (2010). Immune dysregulation by the rheumatoid arthritis shared epitope. J. Immunol. 185, 1927-1934. doi: 10.4049/jimmunol.0904002.
18. Ebert, D. H., and Greenberg, M. E. (2013). Activity-dependent neuronal signaling and autism spectrum disorder. Nature 493, 327-337. doi: 10.1038/nature11860.
19. El-Ansary, A., and Al-Ayadhi, L. (2012). Neuroinflammation in autism spectrum disorders. J. Neuroinflammation 9:265. doi: 10.1186/1742-2094-9-265.
20. Elmer, B. M., Estes, M. L., Barrow, S. L., and McAllister, A. K. (2013). MHCI requires MEF2 transcription factors to negatively regulate synapse density during development and in disease. J. Neurosci. 33, 13791-13804. doi: 10.1523/JNEUROSCI.2366-13.2013.
21. Feitsma, A. L., van der Helm-van Mil, A. H., Huizinga, T. W., de Vries, R. R., and Toes, R. E. (2008). Protection against rheumatoid arthritis by HLA: nature and nurture. Ann. Rheum. Dis. 67(Suppl. 3), 61-63. doi: 10.1136/ard.2008.098509.
22. Ferrante, P., Saresella, M., Guerini, F. R., Marzorati, M., Musetti, M. C., and Cazzullo, A. G. (2003). Significant association of HLA A2-DR11 with CD4 naive decrease in autistic children. Biomed. Pharmacother. 57, 372-374. doi: 10.1016/S0753-3322(03)00099-4.
23. Fisher, R. A. (1918). The correlation between relatives on the supposition of mendelian inheritance. Philos. Trans. R. Soc. Edinburgh 52, 399-433.
24. Gaugler, T., Klei, L., Sanders, S. J., Bodea, C. A., Goldberg, A. P., Lee, A. B., et al. (2014). Most genetic risk for autism resides with common variation. Nat. Genet. 46, 881-885. doi: 10.1038/ng.3039.
25. Goldstein, D. B. (2009). Common genetic variation and human traits. New Engl. J. Med. 360, 1696-1698. doi: 10.1056/NEJMp0806284.
26. Gourraud, P.-A., Khankhanian, P., Cereb, N., Yang, S. Y., Feolo, M., Maiers, M., et al. (2014). HLA diversity in the 1000 genomes dataset. PLoS ONE 9:e97282. doi: 10.1371/journal.pone.0097282.
27. Grether, J. K., Ashwood, P., Van de Water, J., Yolken, R. H., Anderson, M. C., Torres, A. R., et al. (2016). Prenatal and newborn immunoglobulin levels from mother-child pairs and risk of autism spectrum disorders. Front. Neurosci. 10:218. doi: 10.3389/fnins.2016.00218.
28. Grigorenko, E. L., Han, S. S., Yrigollen, C. M., Leng, L., Mizue, Y., Anderson, G. M., et al. (2008). Macrophage migration inhibitory factor and autism spectrum disorders. Pediatrics 122, E438-E445. doi: 10.1542/peds.2007-3604.
29. Guerini, F. R., Bolognesi, E., Chiappedi, M., Ghezzo, A., Canevini, M. P., Mensi, M. M., et al. (2015). An HLA-G(*)14bp insertion/deletion polymorphism associates with the development of autistic spectrum disorders. Brain Behav. Immun. 44, 207-212. doi: 10.1016/j.bbi.2014.10.002.
30. Guerini, F. R., Bolognesi, E., Chiappedi, M., Manca, S., Ghezzo, A., Agliardi, C., et al. (2014). Activating KIR molecules and their cognate ligands prevail in children with a diagnosis of ASD and in their mothers. Brain Behav. Immun. 36, 54-60. doi: 10.1016/j.bbi.2013.10.006.
31. Hess, D. T., Patterson, S. I., Smith, D. S., and Skene, J. H. (1993). Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide. Nature 366, 562-565. doi: 10.1038/366562a0.
32. Horton, R., Gibson, R., Coggill, P., Miretti, M., Allcock, R. J., Almeida, J., et al. (2008). Variation analysis and gene annotation of eight MHC haplotypes: the MHC Haplotype Project. Immunogenetics 60, 1-18, doi: 10.1007/s00251-007-0262-2.
33. Irimia, M., Weatheritt, R. J., Ellis, J. D., Parikshak, N. N., Gonatopoulos-Pournatzis, T., Babor, M., et al. (2014). A highly conserved program of neuronal microexons is misregulated in autistic brains. Cell 159, 1511-1523. doi: 10.1016/j.cell.2014.11.035.
34. Johnson, S. A., Pasinetti, G. M., and Finch, C. E. (1994). Expression of complement C1qB and C4 mRNAs during rat brain development. Dev. Brain Res. 80, 163-174. doi: 10.1016/0165-3806(94)90101-5.
35. Johnson, W. G., Buyske, S., Mars, A. E., Sreenath, M., Stenroos, E. S., Williams, T. A., et al. (2009). HLA-DR4 as a risk allele for autism acting in mothers of probands possibly during pregnancy. Arch. Pediatr. Adolesc. Med. 163, 542-546. doi: 10.1001/archpediatrics.2009.74.
36. Jyonouchi, H., Geng, L., and Davidow, A. L. (2014). Cytokine profiles by peripheral blood monocytes are associated with changes in behavioral symptoms following immune insults in a subset of ASD subjects: an inflammatory subtype? J. Neuroinflammation 11, 187. doi: 10.1186/s12974-014-0187-2.
37. Kendrick, N. (2014). A Gene's mRNA Level Does Not Usually Predict its Protein Level. Madison, WI: Kendrick Laboratories.
38. Krystal, J. H., and State, M. W. (2014). Psychiatric disorders: diagnosis to therapy. Cell 157, 201-214. doi: 10.1016/j.cell.2014.02.042.
39. Lamb, J. A., Moore, J., Bailey, A., and Monaco, A. P. (2000). Autism: recent molecular genetic advances. Hum. Mol. Genet. 9, 861-868. doi: 10.1093/hmg/9.6.861.
40. Laver, T. W., Caswell, R. C., Moore, K. A., Poschmann, J., Johnson, M. B., Owens, M. M., et al. (2016). Pitfalls of haplotype phasing from amplicon-based long-read sequencing. Sci. Rep. 6:21746. doi: 10.1038/srep21746.
41. Lee, L. C., Zachary, A. A., Leffell, M. S., Newschaffer, C. J., Matteson, K. J., and Tyler, J. D. (2006). HLA-DR4 in families with autism. Pediatr. Neurol. 35, 303-307. doi: 10.1016/j.pediatrneurol.2006.06.006.
42. Li, X., Chauhan, A., Sheikh, A. M., Patil, S., Chauhan, V., Li, X. M., et al. (2009). Elevated immune response in the brain of autistic patients. J. Neuroimmunol. 207, 111-116. doi: 10.1016/j.jneuroim.2008.12.002.
43. Liu, J., Shen, Y., Li, M., Lv, D., Zhang, A., Peng, Y., et al. (2015). Spatial-temporal expression of non-classical MHC Class I molecules in the C57 mouse Brain. Neurochem. Res. 40, 1487-1496. doi: 10.1007/s11064-015-1620-3.
44. Lizasoain, I., Weiner, C. P., Knowles, R. G., and Moncada, S. (1996). The ontogeny of cerebral and cerebellar nitric oxide synthase in the guinea pig and rat. Pediatr. Res. 39, 779-783. doi: 10.1203/00006450-199605000-00006.
45. Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., et al. (2009). Finding the missing heritability of complex diseases. Nature 461, 747-753. doi: 10.1038/nature08494.
46. McClellan, J., and King, M. C. (2010). Genetic heterogeneity in human disease. Cell 141, 210-217. doi: 10.1016/j.cell.2010.03.032.
47. McCoy, M. K., and Tansey, M. G. (2008). TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J. Neuroinflammation 5:45. doi: 10.1186/1742-2094-5-45.
48. McQueen, K. L., Dorighi, K. M., Guethlein, L. A., Wong, R., Sanjanwala, B., and Parham, P. (2007). Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hemotopoietic cell transplantation. Hum. Immunol. 68, 309-323. doi: 10.1016/j.humimm.2007.01.019.
49. Montgomery, S. L., and Bowers, W. J. (2012). Tumor necrosis factor-a and the roles it plays in homeostatic and degenerative processes within the central nervous system. J. Neuroimmune Pharmacol. 7, 42-59. doi: 10.1007/s11481-011-9287-2.
50. Mostafa, G. A., and Shehab, A. A. (2010). The link of C4B null allele to autism and to a family history of autoimmunity in Egyptian autistic children. J. Neuroimmunol. 223, 115-119. doi: 10.1016/j.jneuroim.2010.03.025.
51. Nelson, W. C., Pyo, C. W., Vogan, D., Wang, R., Pyon, Y. S., Hennessey, C., et al. (2015). An integrated genotyping approach for HLA and other complex genetic systems. Hum. Immunol. 76, 928-938. doi: 10.1016/j.humimm.2015.05.001.
52. Odell, D., Maciulis, A., Cutler, A., Warren, L., McMahon, W. M., Coon, H., et al. (2005). Confirmation of the association of the C4B null allele in autism. Hum. Immunol. 66, 140-145. doi: 10.1016/j.humimm.2004.11.002.
53. Okada, K., Hashimoto, K., Iwata, Y., Nakamura, K., Tsujii, M., Tsuchiya, K. J., et al. (2007). Decreased serum levels of transforming growth factor-beta1 in patients with autism. Prog. Neuropsychopharmacol. Biol. Psychiatry 31, 187-190. doi: 10.1016/j.pnpbp.2006.08.020.
54. Onore, C., Careaga, M., and Ashwood, P. (2012). The role of immune dysfunction in the pathophysiology of autism. Brain Behav. Immun. 26, 383-392. doi: 10.1016/j.bbi.2011.08.007.
55. Ortutay, C., and Vihinen, M. (2009). Immunome knowledge base (IKB): an integrated service for immunome research. BMC Immunol. 10:3. doi: 10.1186/1471-2172-10-3.
56. Ovsyannikova, I. G., Vierkant, R. A., Pankratz, V. S., Jacobson, R. M., and Poland, G. A. (2010). Extended LTA, TNF, LST1 and HLA gene haplotypes and their association with rubella vaccine-induced immunity. PLoS ONE 5:e1106. doi: 10.1371/journal.pone.0011806.
57. Parham, P., and Moffett, A. (2013). Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat. Rev. Immunol. 13, 133-144. doi: 10.1038/nri3370.
58. Philippe, A., Martinez, M., Guilloud-Bataille, M., Gillberg, C., Råstam, M., Sponheim, E., et al. (1999). Genome-wide scan for autism susceptibility genes. Paris autism research international sibpair study. Hum. Mol. Genet. 8, 805-812. doi: 10.1093/hmg/8.5.805.
59. Puangpetch, A., Suwannarat, P., Chamnanphol, M., Koomdee, N., Ngamsamut, N., Limsila, P., et al. (2015). Significant association of HLA-B alleles and genotypes in Thai children with autism spectrum disorders: a case-control study. Dis. Markers 2015:724935. doi: 10.1155/2015/724935.
60. Pyo, C.-W., Wang, R., Vu, Q., Cereb, N., Yang, S. Y., Duh, F.-M., et al. (2013). Recombinant structures expand and contract inter and intragenic diversification at the KIR locus. BMC Genomics 14:89. doi: 10.1186/1471-2164-14-89.
61. Schoenborn, J. R., and Wilson, C. B. (2007). Regulation of interferon-γ during innate and adaptive immune responses. Adv. Immunol. 96, 41-101. doi: 10.1016/S0065-2776(07)96002-2.
62. Schork, N. J., Murray, S. S., Frazer, K. A., and Topol, E. J. (2009). Common vs. rare allele hypotheses for complex diseases. Curr. Opin. Genet. Dev. 19, 212-219 doi: 10.1016/j.gde.2009.04.010.
63. Shiina, T., Hosomichi, K., Inoko, H., and Kulski, J. K. (2009). The HLA genomic loci map: expression, interaction, diversity and disease. J. Hum. Genet. 54, 15-39. doi: 10.1038/jhg.2008.5.
64. Shiina, T., Inoko, H., and Kulski, J. K. (2004). An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 64, 631-649. doi: 10.1111/j.1399-0039.2004.00327.x.
65. State, M. W. (2010). The genetics of child psychiatric disorders: focus on autism and tourette syndrome. Neuron 68, 254-269. doi: 10.1016/j.neuron.2010.10.004.
66. Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., et al. (2007). The classical complement cascade mediates CNS synapse elimination. Cell 131, 1164-1178. doi: 10.1016/j.cell.2007.10.036.
67. Stubbs, E. G., and Magenis, R. E. (1980). HLA and autism. J. Autism Dev. Disord. 10, 15-19. doi: 10.1007/BF02408429.
68. Stubbs, E. G., Ritvo, E. R., and Mason-Brothers, A. (1985). Autism and shared parental HLA antigens. J. Am. Acad. Child Psychiatry 24, 182. doi: 10.1016/S0002-7138(09)60445-3.
69. Sweeten, T. L., and McDougle, C. J. (2016). "Immunological aspects of autism spectrum disorder, " in Autism Spectrum Disorder, ed C. J. McDougle (Oxford, UK: Oxford University Press).
70. Tao, Y., Gao, H., Ackerman, B., Guo, W., Saffen, D., and Shugart, Y. Y. (2016). Evidence for contribution of common genetic variants within chromosome 8p21.2-8p21.1 to restricted and repetitive behaviors in autism spectrum disorders. BMC Genomics 17:163. doi: 10.1186/s12864-016-2475-y.
71. Tilburgs, T., Evans, J. H., Crespo, â. C., and Strominger, J. L. (2015). The HLA-G cycle provides for both NK tolerance and immunity at the maternal-fetal interface. Proc. Natl. Acad. Sci. U.S.A. 112, 13312-13317. doi: 10.1073/pnas.1517724112.
72. Torres, A., Westover, J., Benson, M., Johnson, R., and Dykes, A. (2016). A killer immunoglobulin-like receptor gene-content haplotype and a cognate human leukocyte antigen ligand are associated with autism. Autism Open Access. 6:171. doi: 10.4172/2165-7890.1000171.
73. Torres, A. R., Maciulis, A., and Odell, D. (2001). The association of MHC genes with autism. Front. Biosci. 6, 936-943. doi: 10.2741/A655.
74. Torres, A. R., Maciulis, A., Stubbs, E. G., Cutler, A., and Odell, D. (2002). The transmission disequilibrium test suggests that HLA-DR4 and DR13 are linked to autism spectrum disorder. Hum. Immunol. 63, 311-316. doi: 10.1016/S0198-8859(02)00374-9.
75. Torres, A. R., Sweeten, T. L., Cutler, A., Bedke, B. J., Fillmore, M., Stubbs, E. G., et al. (2006). The association and linkage of the HLA-A2 class I allele with autism. Hum Immunol. 67, 346-351. doi: 10.1016/j.humimm.2006.01.001.
76. Torres, A. R., Westover, J. B., Gibbons, C., Johnson, R. C., and Ward, D. C. (2012b). Activating killer-cell immunoglobulin-like receptors (KIR) and their cognate HLA ligands are significantly increased in autism. Brain Behav. Immun. 26, 1122-1127. doi: 10.1016/j.bbi.2012.07.014.
77. Torres, A. R., Westover, J. B., and Rosenspire, A. J. (2012a). HLA immune function genes in autism. Autism Res. Treat. 2012:959073. doi: 10.1155/2012/959073.
78. Warren, R. P., Burger, R. A., Odell, D., Torres, A. R., and Warren, W. L. (1994). Decreased plasma concentrations of the C4B complement protein in autism. Arch. Pediatr. Adolesc. Med. 148, 180-183. doi: 10.1001/archpedi.1994.02170020066011.
79. Warren, R. P., Odell, J. D., Warren, W. L., Burger, R. A., Maciulis, A., Daniels, W. W., et al. (1996). Strong association of the third hypervariable region of HLA-DRB1 with autism. J. Neuroimmunol. 67, 97-102. doi: 10.1016/0165-5728(96)00052-5.
80. Warren, R. P., Singh, V. K., Cole, P., Odell, J. D., Pingree, C. B., Warren, W. L., et al. (1991). Increased frequency of the null allele at the complement C4B locus in autism. Clin. Exp. Immunol. 83, 438-440. doi: 10.1111/j.1365-2249.1991.tb05657.x.
81. Westover, J. B., Sweeten, T. L., Benson, M., Bray-Ward, P., and Torres, A. R. (2011). "Immune dysfunction in autism spectrum disorder, " in Autism: A Neurodevelopmental Journey from Genes to Behavior, ed V. Eapen (Rijeka: Intech), 343-368.
82. Young, A. M., Chakrabarti, B., Roberts, D., Lai, M. C., Suckling, J., and Baron-Cohen, S. (2016). From molecules to neural morphology: understanding neuroinflammation in autism spectrum condition. Mol. Autism 7:9. doi: 10.1186/s13229-016-0068-x.
83. Yuen, R. K., Thiruvahindrapuram, B., Merico, D., Walker, S., Tammimies, K., Hoang, N., et al. (2015). Whole-genome sequencing of quartet families with autism spectrum disorder. Nat. Med. 21, 185-191. doi: 10.1038/nm.3792.